CTRE vs LTC

Key Takeaways

• CareTrust REIT (CTRE) and LTC Properties (LTC) are both healthcare REITs (Real Estate Investment Trusts) benefiting from favorable demographic tailwinds tied to an aging U.S. population.
• CTRE has delivered superior scale and earnings momentum, with a market capitalization of approximately $10.2 billion and net margins near 64%, while LTC is a smaller, ~$2.2 billion REIT undergoing a strategic portfolio transformation toward SHOP (Senior Housing Operating Portfolio) assets.
• LTC offers a significantly higher dividend yield of approximately 5.4% compared to CTRE's ~3.7%, making it more attractive to income-oriented investors, though CTRE has a stronger track record of dividend growth.
• Institutional ownership stands at roughly 88% for CTRE versus 69% for LTC, reflecting greater confidence from large money managers in CTRE's scale and execution.
• Both stocks have posted strong year-to-date returns, with CTRE up approximately 22% and LTC up about 27% YTD in 2026, though their growth trajectories and risk profiles differ meaningfully.

Introduction

Investors evaluating healthcare REITs frequently encounter both CTRE and LTC as prominent names in the senior housing and skilled nursing property space. Both companies operate at the intersection of real estate and the powerful demographic trend of an aging American population, yet they differ considerably in scale, strategy, and risk-return profiles. This comparison is particularly relevant for dividend-focused investors, those seeking exposure to the longevity economy, and traders analyzing relative strength within the healthcare REIT sector. By examining business models, recent performance, and market positioning, this article provides a clear, data-driven framework for understanding how these two REITs stack up.

CTRE Overview and Recent Performance

CareTrust REIT, headquartered in Dana Point, California, is a self-administered healthcare REIT that owns, acquires, and leases skilled nursing facilities, senior housing communities, and other healthcare-related properties. Its portfolio spans approximately 579 properties across 33 states and the United Kingdom, following its strategic acquisition of Care REIT plc, which marked its entry into the UK care home market. CTRE primarily operates through triple-net lease arrangements, where tenants bear most property-level expenses, giving the company a relatively predictable income stream with lower operating complexity.

In recent months, CTRE has demonstrated robust financial momentum. For the full year 2025, the company reported normalized FFO (Funds From Operations, a key earnings metric for REITs) of $1.76 per share, representing 17% growth over the prior year, and deployed approximately $1.8 billion into investments at a blended stabilized yield of 8.6%. Net income attributable to CareTrust reached $320.5 million. The company's balance sheet remains a standout feature: net debt-to-EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stood at just 0.7x as of year-end 2025, well below its target leverage range of 4.0x to 5.0x, with full availability on a $1.2 billion revolving credit facility and no debt maturities before 2028. The stock has traded near the upper end of its 52-week range in recent weeks, with shares hovering in the $40–$43 range, supported by a $500 million investment pipeline and 2026 normalized FFO guidance of $1.90 to $1.95 per share.

LTC Overview and Recent Performance

LTC Properties, based in Westlake Village, California, is a healthcare REIT that invests primarily in seniors housing and skilled nursing properties across the United States. Its portfolio encompasses roughly 190 properties with over 16,000 units and beds, operated by 31 partners in 24 states. Historically known as a triple-net lease REIT, LTC has been undergoing a significant strategic transformation since late 2024, aggressively expanding its SHOP segment, which allows the company to participate directly in property-level operating performance rather than relying solely on fixed lease payments.

Recent market activity has reflected this transformation. SHOP assets now represent approximately 24% of LTC's total investment portfolio, up from virtually zero at the start of 2024, and management has set a target of 45% by the end of 2026. The company closed roughly 85% of its projected $460 million pipeline through late 2025, deploying over $290 million into SHOP acquisitions at average year-one yields of about 7%. In a notable portfolio optimization move, LTC sold seven older skilled nursing centers for $123 million, redeploying proceeds into newer, stabilized SHOP communities with an average age of just nine years. Financially, the company delivered diluted Core FFO of $2.69 to $2.71 per share for full-year 2025 and Core FAD (Funds Available for Distribution) of $2.82 to $2.84. Shares have traded in a range of roughly $34 to $43 over the trailing 52 weeks, with the stock recently reaching new 52-week highs amid strong SHOP NOI (Net Operating Income) growth and improving occupancy trends.

Trending AI Robots

For traders and investors seeking a data-driven edge in comparing stocks like CTRE and LTC, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate evolving market conditions. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers across multiple timeframes and strategies, but only those demonstrating the strongest alignment with current market dynamics earn a spot in this exclusive Trending section. These bots employ diverse trading styles — from swing trading and trend following to mean-reversion and breakout strategies — and feature performance track records that include statistics such as annualized returns, win rates, and drawdown metrics. Whether you are looking for short-term tactical signals or longer-term positioning insights, exploring Tickeron's Trending AI Robots can help you identify which names and strategies are resonating most with AI-driven analysis right now.

Head-to-Head Comparison

The most immediate contrast between these two healthcare REITs is scale. CTRE, with a market capitalization near $10.2 billion, is roughly five times larger than LTC at approximately $2.2 billion. This size differential translates into several practical advantages for CTRE: deeper institutional ownership (88% versus 69%), broader analyst coverage, and greater capacity to pursue large-scale acquisitions, including cross-border deals like the Care REIT plc purchase that opened the UK market.

From a profitability standpoint, CTRE holds a clear edge with net margins of approximately 64% compared to roughly 39% for LTC. CTRE's triple-net lease model, where tenants cover taxes, insurance, and maintenance, generates higher-margin rental income, while LTC's growing SHOP segment introduces operating expenses that compress margins but also create upside potential tied to occupancy gains and rental rate growth. Return on equity (ROE) tells a different story: LTC posts an ROE near 10.9% versus CTRE's 8.7%, reflecting LTC's more leveraged capital structure and its ability to generate higher returns on a smaller equity base.

Income investors will note the substantial dividend yield gap. LTC pays $2.28 per share annually, yielding approximately 5.4%, while CTRE's $1.56 annual dividend yields about 3.7%. However, CTRE has raised its dividend for three consecutive years and maintains a conservative payout ratio of roughly 76% of normalized FAD, suggesting room for continued increases. LTC's higher yield comes alongside the execution risk of its SHOP transformation.

Risk profiles diverge meaningfully. CTRE's fortress balance sheet with net debt-to-EBITDA of 0.7x provides exceptional financial flexibility and downside protection. LTC's pivot to SHOP introduces variable operating exposure — occupancy rates, labor costs, and operator performance now matter more — but also offers a potentially higher growth ceiling if the strategy succeeds. Both stocks carry low beta values (CTRE at 0.79, LTC at 0.56), meaning they are less volatile than the broader market, a feature typical of healthcare REITs with stable, needs-based demand.

On valuation, LTC appears cheaper on a trailing P/E (Price-to-Earnings) basis at approximately 16.6x versus CTRE's 27.4x. This discount reflects LTC's smaller size, ongoing strategic transition, and the GAAP earnings noise from non-cash write-offs. CTRE's premium multiple is supported by its superior growth trajectory, international diversification, and best-in-class balance sheet metrics.

Tickeron AI Verdict

Based on observable factors including trend consistency, balance sheet strength, earnings momentum, and relative market positioning, Tickeron's AI would likely show a near-term preference for CTRE over LTC. CTRE's combination of double-digit FFO growth, an exceptionally under-levered balance sheet with no near-term debt maturities, 100% rent collection, a replenishing $500 million investment pipeline, and international diversification through its UK platform creates a more stable and predictable growth profile. While LTC's SHOP transformation is yielding tangible results — including strong NOI expansion, rising occupancy, and portfolio modernization — the strategy introduces greater variability in outcomes that an AI model might view as increasing uncertainty. That said, LTC's lower valuation multiple and higher dividend yield could tilt the probabilistic assessment in its favor for income-focused strategies, particularly if SHOP execution continues to exceed expectations. The AI-driven analysis would likely conclude that both stocks are well-positioned within a favorable demographic backdrop, but CTRE currently offers a more consistent risk-reward profile based on the weight of the available data.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations